Carnosine: the dipeptide in your muscles, and the supplement evidence
Last updated: October 3, 2026 · 8 min read · By the Grey Peptides Editorial Board
- Carnosine is a dipeptide made in your muscles from beta-alanine and histidine. It helps buffer acid during hard exercise.
- Swallowed carnosine is mostly broken down in the blood before reaching muscle, so athletes use beta-alanine to raise muscle carnosine instead.
- Beta-alanine's performance benefit is real but small on average, mainly in efforts lasting about one to ten minutes.
- Claims that carnosine pills slow ageing or prevent glycation come from lab studies; small trials hint at modest blood-sugar effects.
What carnosine is
Carnosine is one of the simplest peptides in the body: two building blocks, beta-alanine and histidine, joined together. It is concentrated in skeletal muscle. A 2013 review describes its chemistry: it buffers acid, binds metals, acts as an antioxidant and protects against products of glycation and lipid oxidation in laboratory systems, and it is broken down in human blood by an enzyme, serum carnosinase (review) 1.
Muscle levels vary widely between people. A study of 149 healthy adults, measuring carnosine in leg muscles by magnetic resonance spectroscopy, found levels can differ four-fold across a population: men had 28% to 82% more than women depending on the muscle, levels in one calf muscle fell with age, and vegetarians had about 26% less in the gastrocnemius than meat-eaters (observational study) 2.
What carnosine does in muscle
During intense exercise, muscles produce acid faster than they can clear it, and the falling pH contributes to fatigue. Carnosine inside muscle cells soaks up some of that acid. The International Society of Sports Nutrition's position stand describes carnosine as acting as an intracellular pH buffer, which is the basis for trying to raise its levels (position stand) 3.
Why swallowing carnosine mostly does not work
The obvious approach, taking carnosine itself, runs into the enzyme that breaks it down. In a 2012 study, 25 healthy people swallowed a large dose of carnosine (60 mg per kg of body weight); only 8 showed a measurable rise in plasma carnosine, and those were the people with low carnosinase activity in their blood (human study) 4. In most people, carnosine is split into beta-alanine and histidine before it gets far.
Because beta-alanine is the scarce building block for making carnosine in muscle, supplementing beta-alanine directly is the route that works. In a 24-week study, 25 active men taking sustained-release beta-alanine or placebo had muscle biopsies every four weeks; carnosine rose from baseline at every time point on beta-alanine (randomised trial) 5.
Which building block limits carnosine?
Carnosine is made from two parts, so why supplement only beta-alanine? A 2017 trial answered it directly: 30 people took beta-alanine, histidine, or both for several weeks. Carnosine rose in all measured muscles with beta-alanine, alone or combined, but did not change with histidine alone, confirming beta-alanine as the limiting building block (randomised trial) 6. The same trial found beta-alanine alone lowered histidine in plasma and muscle by about 30%, which taking histidine alongside prevented 6, a reminder that loading one nutrient can draw down another.
How fast carnosine rises depends on the amount taken. In a trial of 30 men and women, both a higher daily amount for two weeks and a lower one for four weeks raised muscle carnosine against placebo (randomised trial) 7, and the 24-week study found it kept rising over months 5. Our encyclopedia does not give doses; the position stand's figures are quoted only to describe what was studied 3.
Beta-alanine and performance: a small effect
The ISSN position stand concludes that four weeks of beta-alanine at 4 to 6 g daily significantly raises muscle carnosine, that it appears safe in healthy people at recommended doses, that the only reported side effect is tingling (paraesthesia), which divided lower doses or sustained-release forms can reduce, and that 2 to 4 weeks improves performance, most clearly in time trials and open-ended efforts lasting 1 to 4 minutes (position stand) 3.
The size of the effect matters. A 2017 meta-analysis of 40 studies with 1,461 participants found a significant but small overall effect size of 0.18, larger for exercise capacity tests lasting 0.5 to 10 minutes than for performance tests, and largest when combined with sodium bicarbonate (meta-analysis) 8. A 2026 meta-analysis of 17 randomised trials found no significant improvement in repeated-sprint ability, mean or peak, or in fatigue (meta-analysis) 9. In short: a modest edge in sustained hard efforts of a few minutes, not a general performance booster for every sport.
| Question | What the evidence shows |
|---|---|
| Does beta-alanine raise muscle carnosine? | Yes, consistently, in biopsy and spectroscopy studies |
| Does beta-alanine improve performance? | A small average effect, mainly in efforts of about 0.5 to 10 minutes; not in repeated sprints |
| Does swallowed carnosine reach the blood intact? | Mostly not: blood carnosinase breaks it down; only some people show a measurable rise |
| Does carnosine lower blood sugar? | Small trials and a meta-analysis suggest modest effects in prediabetes and type 2 diabetes; not established |
| Does carnosine slow ageing or glycation in people? | Shown in the laboratory; not demonstrated in human outcome trials |
Vegetarians, women and older adults
Because muscle carnosine is lower on average in women, in older people and in vegetarians 2, it is reasonable to ask whether these groups gain more from beta-alanine. The evidence is partial. The ISSN position stand notes that beta-alanine attenuates neuromuscular fatigue, particularly in older subjects (position stand) 3, while the 2017 meta-analysis found no moderating effect of training status on the overall result 8. No trial in what we read tested whether vegetarians benefit more. Lower starting levels make a larger relative rise plausible, but plausibility is not the same as a measured performance gain in a controlled trial.
Carnosine and blood sugar
Carnosine's laboratory anti-glycation effects led to trials in people with metabolic disease. In a 2024 randomised trial, 43 adults with prediabetes or type 2 diabetes took 2 g of carnosine or placebo daily for 14 weeks; carnosine lowered glucose at 90 and 120 minutes of a glucose tolerance test and reduced the total glucose area under the curve, without changes in body composition (randomised trial) 10. An earlier 12-week trial reported fasting glucose 13.1 mg/dL lower and HbA1c 0.6 percentage points lower than placebo with 1 g a day (randomised trial) 11. A 2025 meta-analysis of eight trials with 377 participants found carnosine or beta-alanine lowered fasting glucose and HbA1c against placebo, without significant effects on insulin, body mass index or insulin resistance (meta-analysis) 12.
Not every trial was positive: in 49 people with well-controlled type 2 diabetes, 2 g a day for 14 weeks had no effect on blood pressure, blood-vessel function, arterial stiffness, lipids, or liver and kidney measures (randomised trial) 13. These are small, short trials of surrogate markers. They do not show that carnosine prevents diabetes complications, and it is not a substitute for diabetes treatment.
Glycation and anti-ageing claims
Supplements often sell carnosine as an anti-ageing compound because it limits glycation, the sugar-damage of proteins, in laboratory studies 1. Human evidence for ageing outcomes is thin. In a 2026 trial, 2 g a day for 12 weeks did not differ from placebo on grip strength, walking speed or most other measures, though calf-raise performance rose in people under 40 at six weeks (randomised trial) 14. Laboratory anti-glycation activity, plus rapid breakdown in the blood 4, makes it unlikely that much swallowed carnosine reaches tissues intact to act there.
Other studied uses
Small trials have explored carnosine in other settings, none establishing a use. In heart failure, 500 mg a day of an orodispersible form for six months, added to standard therapy, improved peak oxygen uptake, walking distance and quality of life against standard treatment alone (open randomised trial) 15. In 58 patients with depression, carnosine added to citalopram improved depression scores more than placebo over six weeks (randomised trial) 16. Each needs confirmation in larger, independent, placebo-controlled trials before it could be called a use.
Safety, status and sport
Carnosine is sold as a dietary supplement, not an approved medicine 17. The ISSN considers beta-alanine safe in healthy people at its studied doses, with tingling the only reported side effect 3. Carnosine is not on the WADA Prohibited List 17, though athletes face the general risk that supplements can be contaminated; our WADA hub covers that. Anyone with diabetes taking glucose-lowering drugs should discuss carnosine with their doctor, given the trials suggesting modest glucose effects 12.
Carnosine among food peptides
Carnosine sits alongside other food-derived peptides, such as collagen peptides, and the tripeptide glutathione, that share a problem: digestion and blood enzymes break small peptides down, so what is swallowed often is not what reaches tissues. Our guide to how peptides are made and half-life guide explain why.
The bottom line
Carnosine is a real, important muscle dipeptide that buffers acid during hard exercise. Swallowing it mostly fails because blood enzymes break it down, which is why athletes take beta-alanine, which raises muscle carnosine and gives a small, reliable edge in efforts of a few minutes. Claims for carnosine pills against ageing and glycation rest on laboratory work; small trials suggest modest blood-sugar effects in people with prediabetes or diabetes, not yet a proven treatment.
Frequently asked questions
What is carnosine?
A dipeptide made from beta-alanine and histidine, concentrated in skeletal muscle, where it helps buffer acid during intense exercise.
Is carnosine or beta-alanine better?
For raising muscle carnosine, beta-alanine. Swallowed carnosine is mostly broken down by blood carnosinase; in one study only 8 of 25 people showed a measurable plasma rise.
Does beta-alanine improve performance?
Slightly. A 2017 meta-analysis found an overall effect size of 0.18, mainly in efforts of about 0.5 to 10 minutes; a 2026 meta-analysis found no benefit for repeated sprints.
Does carnosine lower blood sugar?
Small trials and a 2025 meta-analysis suggest modest reductions in fasting glucose and HbA1c in prediabetes and type 2 diabetes. It is not an established treatment.
Does carnosine slow ageing?
Laboratory studies show anti-glycation effects, but human trials have not shown ageing benefits; a 2026 trial found no difference from placebo on most physical measures.
Related on Grey Peptides
Sources
- Boldyrev, A. A., et al. (2013). Physiology and pathophysiology of carnosine. Physiol Rev, 93(4), 1803-45. PMID: 24137022
- Everaert, I., et al. (2011). Vegetarianism, female gender and increasing age, but not CNDP1 genotype, are associated with reduced muscle carnosine levels in humans. Amino Acids, 40(4), 1221-9. PMID: 20865290
- Trexler, E. T., et al. (2015). International society of sports nutrition position stand: Beta-Alanine. J Int Soc Sports Nutr, 12, 30. PMID: 26175657
- Everaert, I., et al. (2012). Low plasma carnosinase activity promotes carnosinemia after carnosine ingestion in humans. Am J Physiol Renal Physiol, 302(12), F1537-44. PMID: 22496410
- Saunders, B., et al. (2017). Twenty-four Weeks of β-Alanine Supplementation on Carnosine Content, Related Genes, and Exercise. Med Sci Sports Exerc, 49(5), 896-906. PMID: 28157726
- Blancquaert, L., et al. (2017). Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage. Med Sci Sports Exerc, 49(3), 602-609. PMID: 28106620
- Church, D. D., et al. (2017). Comparison of Two β-Alanine Dosing Protocols on Muscle Carnosine Elevations. J Am Coll Nutr, 36(8), 608-616. PMID: 28910200
- Saunders, B., et al. (2017). β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med, 51(8), 658-669. PMID: 27797728
- Liang, W., et al. (2026). No ergogeniceffect of β-alanine on repeated sprint ability: a systematic review and multilevel meta-analysis of randomized controlled trials. Front Nutr, 13, 1818755. PMID: 41971372
- Hariharan, R., et al. (2024). Carnosine supplementation improves glucose control in adults with pre-diabetes and type 2 diabetes: A randomised controlled trial. Nutr Metab Cardiovasc Dis, 34(2), 485-496. PMID: 38172006
- Houjeghani, S., et al. (2018). l-Carnosine supplementation attenuated fasting glucose, triglycerides, advanced glycation end products, and tumor necrosis factor-α levels in patients with type 2 diabetes: a double-blind placebo-controlled randomized clinical trial. Nutr Res, 49, 96-106. PMID: 29420997
- Li, N., et al. (2025). Effect of carnosine or beta-alanine supplementation therapy for prediabetes or type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. BMC Endocr Disord, 25(1), 210. PMID: 40999397
- Saadati, S., et al. (2023). Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial. Nutrients, 15(22). PMID: 38004228
- O'Toole, T. E., et al. (2026). Effects of carnosine supplementation on physical endurance: a placebo-controlled randomized clinical trial. J Int Soc Sports Nutr, 23(1), 2679716. PMID: 42308284
- Lombardi, C., et al. (2015). Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure. Nutrition, 31(1), 72-8. PMID: 25287762
- Araminia, B., et al. (2020). L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial. J Affect Disord, 267, 131-136. PMID: 32063564
- Grey Peptides encyclopedia entry for carnosine (supplement status; WADA not listed). Read October 3, 2026.
Educational information, not medical advice. Each dose in this guide names its source, an approved label or a published study. None is a recommendation for you. An unapproved compound has no established safe or effective human dose, and products sold for “research use only” are not made or tested for people. Talk to a doctor before acting on anything on this site, including before you start, stop or change any medicine or dose.
New guides and rule changes, by email
One short email when a peptide's legal status moves — an FDA or PCAC decision, a WADA list change, an enforcement action — plus new guides and tools. At most one a week, and none when nothing changes. The newsletter has not started sending yet: your first email will be its first issue.
We keep your email address and the page you signed up from, nothing else. How it works · Privacy · RSS instead